Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Express Scripts
Fuji
Covington
Chubb
Teva
Boehringer Ingelheim
Healthtrust
Julphar

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201832

« Back to Dashboard

NDA 201832 describes NIMODIPINE, which is a drug marketed by Bionpharma Inc, Heritage Pharms Inc, Sofgen Pharms, Sun Pharm Inds Inc, and Thepharmanetwork Llc, and is included in five NDAs. It is available from eleven suppliers. Additional details are available on the NIMODIPINE profile page.

The generic ingredient in NIMODIPINE is nimodipine. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the nimodipine profile page.
Summary for 201832
Tradename:NIMODIPINE
Applicant:Sofgen Pharms
Ingredient:nimodipine
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 201832
Ingredient-typeDihydropyridines
Mechanism of ActionCalcium Channel Antagonists
Medical Subject Heading (MeSH) Categories for 201832
Suppliers and Packaging for NDA: 201832
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIMODIPINE nimodipine CAPSULE;ORAL 201832 ANDA ANI Pharmaceuticals, Inc. 62559-210 62559-210-31 30 CAPSULE in 1 CARTON (62559-210-31)
NIMODIPINE nimodipine CAPSULE;ORAL 201832 ANDA ANI Pharmaceuticals, Inc. 62559-210 62559-210-52 10 CAPSULE in 1 BLISTER PACK (62559-210-52)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Jul 24, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Novartis
Chubb
Deloitte
Cantor Fitzgerald
AstraZeneca
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot